These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27151911)

  • 1. The effect of diosmin on the pharmacokinetics of fexofenadine in healthy human volunteers.
    Bedada SK; Boga PK; Kotakonda HK
    Xenobiotica; 2017 Mar; 47(3):230-235. PubMed ID: 27151911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers.
    Bedada SK; Boga PK
    Eur J Clin Pharmacol; 2017 Mar; 73(3):343-349. PubMed ID: 27981349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
    Bedada SK; Boga PK
    Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats.
    Neerati P; Bedada SK
    Pharmacol Rep; 2015 Apr; 67(2):339-44. PubMed ID: 25712660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of breviscapine and C3435T
    Zhao Y; Miao Z; Jiang M; Zhou X; Lai Y
    Xenobiotica; 2021 Mar; 51(3):366-372. PubMed ID: 33256506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition.
    Bedada SK; Yellu NR; Neerati P
    Pharmacol Rep; 2016 Apr; 68(2):338-43. PubMed ID: 26922536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.
    Bedada SK; Appani R; Boga PK
    Drug Dev Ind Pharm; 2017 Jun; 43(6):932-938. PubMed ID: 28102715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on modulation of human P-gp by multiple doses of Radix Astragali extract granules using fexofenadine as a phenotyping probe.
    Zhou Q; Ye Z; Ruan Z; Zeng S
    J Ethnopharmacol; 2013 Apr; 146(3):744-9. PubMed ID: 23422332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics.
    Yamada S; Yasui-Furukori N; Akamine Y; Kaneko S; Uno T
    Ther Drug Monit; 2009 Dec; 31(6):764-8. PubMed ID: 19855315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
    Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
    Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers.
    Kim KA; Park JY
    Eur J Clin Pharmacol; 2010 Jul; 66(7):721-5. PubMed ID: 20306185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y; Miura M; Yasui-Furukori N; Ieiri I; Uno T
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
    Yamazaki A; Kumagai Y; Yamane N; Tozuka Z; Sugiyama Y; Fujita T; Yokota S; Maeda M
    J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys.
    Ogasawara A; Kume T; Kazama E
    Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
    Tateishi T; Miura M; Suzuki T; Uno T
    Br J Clin Pharmacol; 2008 May; 65(5):693-700. PubMed ID: 18294330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.
    Kim KA; Park PW; Park JY
    Eur J Clin Pharmacol; 2009 Jun; 65(6):609-14. PubMed ID: 19221726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T; Shimizu M; Sugawara K; Tateishi T
    Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.